Skip Ribbon Commands Skip to main content

Welcome to Wits RHI

Tackling Africa’s
Health Challenges
through science and innovation
Tackling Africa’s
Health Challenges
through science and innovation
Tackling Africa’s
Health Challenges
through science and innovation
Tackling Africa’s
Health Challenges
through science and innovation
Tackling Africa’s
Health Challenges
through science and innovation

Resources & Publications

Causes of Death on Antiretroviral Therapy: A Post-Mortem Study from South Africa

Researchers from the Wits Reproductive Health & HIV Institute (WRHI) in Johannesburg, South Africa, in the first pathological study to address why HIV patients on antiretroviral therapy die, have learned that the vast majority of deaths are due to tuberculosis (TB) .... Learn More

Knowledge Centre

Incidence of Nevirapine-associated hepatitis in an Antenatal Clinic

Pregnant women who were initiated nevirapine-containing ART regimens from July 2004 to December 2006 were included in this analysis. Once initiated on ART, these women were followed up weekly for the first 4 weeks and then 2-4-weekly until delivery. From October 2005 women were followed up 10 weeks post-partum.

Our Clinics